The FDA has approved four updated COVID-19 vaccines for the 2026–2027 season as cases rise across much of the United States.

A recent shot of the COVID-19 vaccine doubled survival time in glioblastoma patients who had undergone tumor biopsy or surgery.

CAMBRIDGE, MA / ACCESS Newswire / August 27, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and ...

The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies ...

Add Yahoo as a preferred source to see more of our stories on Google. With a little help, your immune cells can be potent tumor killers. Steve Gschmeissner/Science Photo Library via Getty Images The ...

The FDA approved an updated round of COVD-19 vaccines for the 2026-2027 respiratory disease season that target circulating ...

The mass-produced COVID-19 vaccines built using the mRNA model – which were rapidly manufactured during the global pandemic – could also help the immune system recognise and attack cancer tumours, new ...

Updated COVID vaccines are necessary, just as flu vaccines are updated because immunity wanes with time, even among those ...

COVID-19 vaccines from Pfizer and Moderna should be pulled from circulation, a former Centers for Disease Control and Prevention official said in a new interview. “I really would like to see the mRNA ...

Moderna, the biotechnology company that rose to prominence with one of the first messenger RNA vaccines against COVID-19, has ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we ...